{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:25:00Z","timestamp":1767986700060,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s13730-020-00527-0","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T11:52:52Z","timestamp":1599738772000},"page":"106-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A classic variant of Fabry disease in a family with the M296I late-onset variant"],"prefix":"10.1007","volume":"10","author":[{"given":"Shuma","family":"Hirashio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4271-9964","authenticated-orcid":false,"given":"Takao","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"527_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","volume":"162","author":"M Ries","year":"2003","unstructured":"Ries M, Ramaswami U, Parini R, Lindblad B, Whybra C, Willers I, et al. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr. 2003;162:767\u201372.","journal-title":"Eur J Pediatr"},{"key":"527_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/jmedgenet-2015-103486","volume":"53","author":"A Ortiz","year":"2016","unstructured":"Ortiz A, Abiose A, Bichet DG, Cabrera G, Charrow J, Germain DP, et al. Time to treatment benefit for adult patients with Fabry disease receiving agalsidase: data from the Fabry Registry. J Med Genet. 2016;53:495\u2013502.","journal-title":"J Med Genet"},{"key":"527_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/medicina55050122","volume":"55","author":"A \u010cerkauskaite","year":"2019","unstructured":"\u010cerkauskaite A, \u010cerkauskiene R, Miglinas M, Laurinavi\u010dius A, Ding C, Rolfs A, et al. Genotype-phenotype correlation in a new fabry-disease-causing mutation. Medicina (Kaunas). 2019;55:122.","journal-title":"Medicina (Kaunas)"},{"key":"527_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3109\/0886022X.2012.669300","volume":"34","author":"T Nishino","year":"2012","unstructured":"Nishino T, Obata Y, Furusu A, Hirose M, Shinzato K, Hattori K, et al. Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients. Ren Fail. 2012;34:566\u201370.","journal-title":"Ren Fail"},{"key":"527_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.gene.2015.09.088","volume":"575","author":"H Peng","year":"2016","unstructured":"Peng H, Xu X, Zhang L, Zhang X, Peng H, Zheng Y, et al. GLA variation pE66Q identified as the genetic etiology of Fabry disease using exome sequencing. Gene. 2016;575:363\u20137.","journal-title":"Gene"},{"key":"527_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An late-onset variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333:288\u201393.","journal-title":"N Engl J Med"},{"key":"527_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2169\/internalmedicine.0959-18","volume":"58","author":"S Yamamoto","year":"2019","unstructured":"Yamamoto S, Nagasawa T, Sugimura K, Kanno A, Tatebe S, Aoki T, et al. Clinical diversity in patients with anderson-fabry disease with the R301Q mutation. Intern Med. 2019;58:603\u20137.","journal-title":"Intern Med"},{"key":"527_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/mgg3.292","volume":"5","author":"R Mignani","year":"2017","unstructured":"Mignani R, Moschella M, Cenacchi GA, Donati I, Flachi M, Grimaldi D, et al. Different renal phenotypes in related adult males with Fabry disease with the same classic genotype. Mol Genet Genomic Med. 2017;5:438\u201342.","journal-title":"Mol Genet Genomic Med"},{"key":"527_CR9","doi-asserted-by":"publisher","first-page":"504784","DOI":"10.1155\/2015\/504784","volume":"2015","author":"G Cammarata","year":"2015","unstructured":"Cammarata G, Fatuzzo P, Rodolico MS, Colomba P, Sicurella L, Iemolo F, et al. High variability of fabry disease manifestations in an extended italian family. Biomed Res Int. 2015;2015:504784.","journal-title":"Biomed Res Int."},{"key":"527_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/cge.12261","volume":"86","author":"M Rigoldi","year":"2014","unstructured":"Rigoldi M, Concolino D, Morrone A, Pieruzzi F, Ravaglia R, Furlan F, et al. Intrafamilial phenotypic variability in four families with anderson-fabry disease. Clin Genet. 2014;86:258\u201363.","journal-title":"Clin Genet"},{"key":"527_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s41100-016-0081-8","volume":"2","author":"A Saito","year":"2016","unstructured":"Saito A, Kimura T, Takeuchi Y, Matsuda K, Fukami H, Sato H, et al. A case of rapid progression of Fabry nephropathy with remarkable glomerulomegaly: a case report and mini literature review of weak response to enzyme replacement therapy. Renal Replacement Ther. 2016;2:69\u201378.","journal-title":"Renal Replacement Ther"},{"key":"527_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/cge.12590","volume":"89","author":"J Politei","year":"2016","unstructured":"Politei J, Schenone AB, Cabrera G, Heguilen R, Szlago M. Fabry Disease and Enzyme Replacement Therapy in Classic Patients With Same Mutation: different Formulations-Different Outcome? Clin Genet. 2016;89:88\u201392.","journal-title":"Clin Genet"},{"key":"527_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","volume":"91","author":"R Schiffmann","year":"2017","unstructured":"Schiffmann R, Hughes DA, Linthorst GE, Ortiz A, Svarstad E, Warnock DG, et al. Screening, diagnosis, and management of patients with Fabry disease: conclusions from a \u201ckidney disease: improving global outcomes\u201d (KDIGO) controversies conference. Kidney Int. 2017;91:284\u201393.","journal-title":"Kidney Int"},{"key":"527_CR14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/bmj.2.5367.1215","volume":"2","author":"JR Anderson","year":"1963","unstructured":"Anderson JR. The lyon hypothesis. Br Med J. 1963;2:1215\u20136.","journal-title":"Br Med J"},{"key":"527_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ymgme.2017.07.012","volume":"122","author":"S Hassan","year":"2017","unstructured":"Hassan S, Sidransky E, Tayebi N. The role of epigenetics in lysosomal strage disorder: uncharted territory. Mol Genet Metab. 2017;122:10\u20138.","journal-title":"Mol Genet Metab"},{"key":"527_CR16","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2215\/CJN.01820217","volume":"12","author":"R Skrunes","year":"2017","unstructured":"Skrunes R, T\u00f8ndel C, Leh S, Larsen KK, Houge G, Davidsen ES, et al. Long-term dose-dependent agalsidase effects on kidney histology in fabry disease. Clin J Am Soc Nephrol. 2017;12:1470\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"527_CR17","doi-asserted-by":"publisher","first-page":"5374746","DOI":"10.1155\/2016\/5374746","volume":"2016","author":"M Abe","year":"2016","unstructured":"Abe M, Okada K, Maruyama N, Takashima H, Oikawa O, Soma M. Comparison of clinical trajectories before initiation of renal replacement therapy between diabetic nephropathy and nephrosclerosis on the KDIGO guidelines heat map. J Diabetes Res. 2016;2016:5374746.","journal-title":"J Diabetes Res"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00527-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-020-00527-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00527-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T23:41:06Z","timestamp":1631144466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-020-00527-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1007\/s13730-020-00527-0","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,9]]},"assertion":[{"value":"13 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in these studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written consent to publish this information was obtained from the patient\u2019s parent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}